Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald

October 16, 2026 7:33 AM EDT Send to a Friend
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $28.00 price target on Pfizer (NYSE: PFE).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login